MeVis Medical Solutions AG Shareholders’ Equity Growth & History (M3V)

MeVis Medical Solutions AG's shareholders’ equity was €17.8M for fiscal 2025.

View full MeVis Medical Solutions AG company overview

MeVis Medical Solutions AG annual shareholders’ equity history

MeVis Medical Solutions AG annual shareholders’ equity

Fiscal yearPeriod endedShareholders’ equityChangeGrowth
20252025-09-30€17.8M€00.00%
20242024-09-30€17.8M€00.00%
20232023-09-30€17.8M€00.00%
20222022-09-30€17.8M€00.00%
20212021-09-30€17.8M€00.00%
20202020-09-30€17.8M€00.00%
20192019-09-30€17.8M−€14.2M−44.39%
20182018-09-30€32.1M−€450,000−1.38%
20172017-09-30€32.5M−€380,000−1.16%
20162016-09-30€32.9M−€840,000−2.49%
20152015-09-30€33.7M€3.5M+11.43%
20142014-09-30€30.3M€3.8M+14.49%
20132013-09-30€26.4M€3.7M+16.12%
20122012-09-30€22.8M€2.0M+9.84%
20112011-09-30€20.7M−€4.1M−16.38%
20102010-09-30€24.8M

MeVis Medical Solutions AG shareholders’ equity trends

Over the last five fiscal years, MeVis Medical Solutions AG's shareholders’ equity increased from €17.8M to €17.8M, a change of €0. The latest reported quarter, Q2 2026, shows €17.8M.

About the metric

What shareholders’ equity means

Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.

Calculation and source

reported shareholders’ equity

TickerStat standardizes stockholders’ or shareholders’ equity reported in company official filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review MeVis Medical Solutions AG source filings ↗

Community posts

It’s quiet here.

No posts about M3V yet. Start the conversation.

Write the first post